JESSICA WINKLEMAN: Open Payments
NPI 1043741234 · SPRINGFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,013 in 30 payments from 8 companies in 2025. Trend: 2023 $264 · 2024 $504 · 2025 $1,013
Food & beverage: $1,013
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 8 | $451 |
| ABBVIE INC. | 6 | $173 |
| Regeneron Healthcare Solutions, Inc. | 1 | $94 |
| Ardelyx, Inc. | 4 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $75 |
| Janssen Biotech, Inc. | 4 | $71 |
| GENZYME CORPORATION | 1 | $41 |
| Aimmune Therapeutics, Inc. | 2 | $30 |
Products named: REZDIFFRA, DUPIXENT, SKYRIZI, IBSRELA, ENTYVIO, TREMFYA, VOWST, ZENPEP.
Industry payments across IL — which companies pay providers there.
